Interim (3 months) analysis of the safety of intravitreal triamcinolone for diabetic macular oedema that persists after laser treatment. Results from a randomized clinical trial: TDMO. - Sutter,F.KP.; Gillies,M.C. (Invest Ophthalmol Vis Sci, 2003)